Canada Exosomes Market Size & Outlook, 2026-2033
- Biotechnology
- RNA analysis
- Exosomes Market Outlook
- RNA analysis
Global Market
Related Markets
Ask Prism AI anything about the exosomes market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Canada exosomes market highlights
- The Canada exosomes market generated a revenue of USD 6.9 million in 2024 and is expected to reach USD 29.6 million by 2030.
- The Canada market is expected to grow at a CAGR of 27.8% from 2025 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2024.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2024 | USD 6.9 million |
| Market revenue in 2030 | USD 29.6 million |
| Growth rate | 27.8% (CAGR from 2025 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, Canada accounted for 3.9% of the global exosomes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. exosomes market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 442.1 million by 2030.
Funds offered by the Canadian government to drive innovations for the development of its healthcare sector are expected to boost the market. Canadian funding agencies are expected to play a significant role in market growth.
The Atlantic Cancer Research Institute, a Canadian nonprofit organization, has developed a highly efficient and flexible tool for the isolation and purification of exosomes from biofluids. The institute currently provides a license for the use of its exosome isolation technique to companies and research institutes for the further study of exosomes in disease management.
For instance, in March 2017, it licensed out Vn96 synthetic peptide, one of the leading technologies for the isolation of exosomes from body fluids, to biotechnology company Bio Vendor for research related to the development of tests and immunoassays.
No credit card required*
Publish Date: May 05, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | www.miltenyibiotec.com |
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | roosterbio.com |
Canada Exosomes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 59.42% in 2024.
Horizon Databook has segmented the Canada exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Funds offered by the Canadian government to drive innovations for the development of its healthcare sector are expected to boost the market. Canadian funding agencies are expected to play a significant role in market growth.
The Atlantic Cancer Research Institute, a Canadian nonprofit organization, has developed a highly efficient and flexible tool for the isolation and purification of exosomes from biofluids. The institute currently provides a license for the use of its exosome isolation technique to companies and research institutes for the further study of exosomes in disease management.
For instance, in March 2017, it licensed out Vn96 synthetic peptide, one of the leading technologies for the isolation of exosomes from body fluids, to biotechnology company Bio Vendor for research related to the development of tests and immunoassays.
- Canada Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Isolation Methods
- Downstream Analysis
- Canada Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Kits & Reagents
- Instruments
- Services
- Canada Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & diagnostics centers
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Canada Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Neurodegenerative diseases
- Cardiovascular diseases
- Others
- Cancer
- Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
- Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Exosomes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Canada Exosomes Market, 2021-2033 (US$M)
Canada exosomes market statistics, by workflow, 2021-2033 (US$M)
